Seminars in Clinical Psychopharmacology
Herausgeber: Haddad, Peter M; Nutt, David J
Seminars in Clinical Psychopharmacology
Herausgeber: Haddad, Peter M; Nutt, David J
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Expanded from previous editions, and integrating basic science, psychopharmacology and clinical practice with up-to-date clinical guidelines.
Andere Kunden interessierten sich auch für
- S Nassir GhaemiClinical Psychopharmacology184,99 €
- Joanna MoncrieffA Straight Talking Introduction to Psychiatric Drugs17,99 €
- Arash AnsariPsychopharmacology95,99 €
- Seminars in the Psychiatry of Intellectual Disability56,99 €
- Seminars in Liaison Psychiatry49,99 €
- Ramzy Yassa / N. P. V. Nair / Dilip V. Jeste (eds.)Neuroleptic-Induced Movement Disorders137,99 €
- Xaviant HazeLiquid Conspiracy 217,99 €
-
-
-
Expanded from previous editions, and integrating basic science, psychopharmacology and clinical practice with up-to-date clinical guidelines.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- 3rd Revised edition
- Seitenzahl: 690
- Erscheinungstermin: 23. Juli 2020
- Englisch
- Abmessung: 231mm x 191mm x 30mm
- Gewicht: 1134g
- ISBN-13: 9781911623458
- ISBN-10: 1911623451
- Artikelnr.: 57391027
- Verlag: Cambridge University Press
- 3rd Revised edition
- Seitenzahl: 690
- Erscheinungstermin: 23. Juli 2020
- Englisch
- Abmessung: 231mm x 191mm x 30mm
- Gewicht: 1134g
- ISBN-13: 9781911623458
- ISBN-10: 1911623451
- Artikelnr.: 57391027
List of contributors; Foreword Peter Tyrer; Preface; Editor's note on
nomenclature; Neuroscience-based nomenclature glossary; List of
abbreviations; Part I. Basic Science and General Principles: 1. A brief
history of psychopharmacology Peter M. Haddad, David J. Nutt and Richard
Green; 2. Psychiatric drug discovery and development Mohammed Shahid,
Joanna C. Neill and John Hutchison; 3. Neurotransmission and mechanisms of
drug action Brian E. Leonard; 4. Pharmacodynamics and pharmacokinetics
Stuart Gill-Banham and David Taylor; 5. Pharmacogenomics and
psychopharmacology Diego L. Lapetina, Esther H. Yang, Beatriz C. Henriques
and Katherine J. Aitchison; 6. Good clinical practice in psychopharmacology
Peter M. Haddad and Thomas R. E. Barnes; Part II. Psychopharmacology of the
Main Psychotropic Drug Groups: 7. Drugs to treat depression Patrick
McLaughlin and Anthony Cleare; 8. Drugs to treat anxiety and insomnia David
S. Baldwin and Nathan Huneke; 9. Drugs to treat schizophrenia and psychosis
(dopamine antagonists and partial agonists other than clozapine) Robert
McCutcheon, Stephen J. Kaar and Oliver D. Howes; 10. Clozapine Richard
Drake; 11. Lithium Allan H. Young and Dilveer S. Sually; 12.
Anticonvulsants for mental disorders: valproate, lamotrigine,
carbamazepine, and oxcarbazepine Peter S. Talbot; 13. Drugs to treat
attention deficit hyperactivity disorder (ADHD) Ulrich Müller-Sedgwick and
Jane A. Sedgwick-Müller; 14. Drugs to treat dementia Ross Dunne and
Alistair Burns; 15. Drugs to treat substance use disorder (SUD) Julia
Sinclair and Lesley Peters; 16. ECT and neuromodulation therapies David
Christmas and Keith Matthews; Part III. Specific Therapeutic Areas: 17.
Drug treatment in childhood and adolescence David Coghill and Nicoletta
Adamo; 18. Drug treatment in later life Simon J. C. Davies; 19. Prescribing
in pregnancy and lactation Angelika Wieck and Ian Jones; 20. The clinical
management of acute disturbance including rapid tranquilisation Faisil
Sethi, Caroline Parker, Aileen O'Brien and Maxine X. Patel; 21.
Antipsychotics, weight gain and metabolic risk Stephen J. Cooper and Gavin
P. Reynolds; Index.
nomenclature; Neuroscience-based nomenclature glossary; List of
abbreviations; Part I. Basic Science and General Principles: 1. A brief
history of psychopharmacology Peter M. Haddad, David J. Nutt and Richard
Green; 2. Psychiatric drug discovery and development Mohammed Shahid,
Joanna C. Neill and John Hutchison; 3. Neurotransmission and mechanisms of
drug action Brian E. Leonard; 4. Pharmacodynamics and pharmacokinetics
Stuart Gill-Banham and David Taylor; 5. Pharmacogenomics and
psychopharmacology Diego L. Lapetina, Esther H. Yang, Beatriz C. Henriques
and Katherine J. Aitchison; 6. Good clinical practice in psychopharmacology
Peter M. Haddad and Thomas R. E. Barnes; Part II. Psychopharmacology of the
Main Psychotropic Drug Groups: 7. Drugs to treat depression Patrick
McLaughlin and Anthony Cleare; 8. Drugs to treat anxiety and insomnia David
S. Baldwin and Nathan Huneke; 9. Drugs to treat schizophrenia and psychosis
(dopamine antagonists and partial agonists other than clozapine) Robert
McCutcheon, Stephen J. Kaar and Oliver D. Howes; 10. Clozapine Richard
Drake; 11. Lithium Allan H. Young and Dilveer S. Sually; 12.
Anticonvulsants for mental disorders: valproate, lamotrigine,
carbamazepine, and oxcarbazepine Peter S. Talbot; 13. Drugs to treat
attention deficit hyperactivity disorder (ADHD) Ulrich Müller-Sedgwick and
Jane A. Sedgwick-Müller; 14. Drugs to treat dementia Ross Dunne and
Alistair Burns; 15. Drugs to treat substance use disorder (SUD) Julia
Sinclair and Lesley Peters; 16. ECT and neuromodulation therapies David
Christmas and Keith Matthews; Part III. Specific Therapeutic Areas: 17.
Drug treatment in childhood and adolescence David Coghill and Nicoletta
Adamo; 18. Drug treatment in later life Simon J. C. Davies; 19. Prescribing
in pregnancy and lactation Angelika Wieck and Ian Jones; 20. The clinical
management of acute disturbance including rapid tranquilisation Faisil
Sethi, Caroline Parker, Aileen O'Brien and Maxine X. Patel; 21.
Antipsychotics, weight gain and metabolic risk Stephen J. Cooper and Gavin
P. Reynolds; Index.
List of contributors; Foreword Peter Tyrer; Preface; Editor's note on
nomenclature; Neuroscience-based nomenclature glossary; List of
abbreviations; Part I. Basic Science and General Principles: 1. A brief
history of psychopharmacology Peter M. Haddad, David J. Nutt and Richard
Green; 2. Psychiatric drug discovery and development Mohammed Shahid,
Joanna C. Neill and John Hutchison; 3. Neurotransmission and mechanisms of
drug action Brian E. Leonard; 4. Pharmacodynamics and pharmacokinetics
Stuart Gill-Banham and David Taylor; 5. Pharmacogenomics and
psychopharmacology Diego L. Lapetina, Esther H. Yang, Beatriz C. Henriques
and Katherine J. Aitchison; 6. Good clinical practice in psychopharmacology
Peter M. Haddad and Thomas R. E. Barnes; Part II. Psychopharmacology of the
Main Psychotropic Drug Groups: 7. Drugs to treat depression Patrick
McLaughlin and Anthony Cleare; 8. Drugs to treat anxiety and insomnia David
S. Baldwin and Nathan Huneke; 9. Drugs to treat schizophrenia and psychosis
(dopamine antagonists and partial agonists other than clozapine) Robert
McCutcheon, Stephen J. Kaar and Oliver D. Howes; 10. Clozapine Richard
Drake; 11. Lithium Allan H. Young and Dilveer S. Sually; 12.
Anticonvulsants for mental disorders: valproate, lamotrigine,
carbamazepine, and oxcarbazepine Peter S. Talbot; 13. Drugs to treat
attention deficit hyperactivity disorder (ADHD) Ulrich Müller-Sedgwick and
Jane A. Sedgwick-Müller; 14. Drugs to treat dementia Ross Dunne and
Alistair Burns; 15. Drugs to treat substance use disorder (SUD) Julia
Sinclair and Lesley Peters; 16. ECT and neuromodulation therapies David
Christmas and Keith Matthews; Part III. Specific Therapeutic Areas: 17.
Drug treatment in childhood and adolescence David Coghill and Nicoletta
Adamo; 18. Drug treatment in later life Simon J. C. Davies; 19. Prescribing
in pregnancy and lactation Angelika Wieck and Ian Jones; 20. The clinical
management of acute disturbance including rapid tranquilisation Faisil
Sethi, Caroline Parker, Aileen O'Brien and Maxine X. Patel; 21.
Antipsychotics, weight gain and metabolic risk Stephen J. Cooper and Gavin
P. Reynolds; Index.
nomenclature; Neuroscience-based nomenclature glossary; List of
abbreviations; Part I. Basic Science and General Principles: 1. A brief
history of psychopharmacology Peter M. Haddad, David J. Nutt and Richard
Green; 2. Psychiatric drug discovery and development Mohammed Shahid,
Joanna C. Neill and John Hutchison; 3. Neurotransmission and mechanisms of
drug action Brian E. Leonard; 4. Pharmacodynamics and pharmacokinetics
Stuart Gill-Banham and David Taylor; 5. Pharmacogenomics and
psychopharmacology Diego L. Lapetina, Esther H. Yang, Beatriz C. Henriques
and Katherine J. Aitchison; 6. Good clinical practice in psychopharmacology
Peter M. Haddad and Thomas R. E. Barnes; Part II. Psychopharmacology of the
Main Psychotropic Drug Groups: 7. Drugs to treat depression Patrick
McLaughlin and Anthony Cleare; 8. Drugs to treat anxiety and insomnia David
S. Baldwin and Nathan Huneke; 9. Drugs to treat schizophrenia and psychosis
(dopamine antagonists and partial agonists other than clozapine) Robert
McCutcheon, Stephen J. Kaar and Oliver D. Howes; 10. Clozapine Richard
Drake; 11. Lithium Allan H. Young and Dilveer S. Sually; 12.
Anticonvulsants for mental disorders: valproate, lamotrigine,
carbamazepine, and oxcarbazepine Peter S. Talbot; 13. Drugs to treat
attention deficit hyperactivity disorder (ADHD) Ulrich Müller-Sedgwick and
Jane A. Sedgwick-Müller; 14. Drugs to treat dementia Ross Dunne and
Alistair Burns; 15. Drugs to treat substance use disorder (SUD) Julia
Sinclair and Lesley Peters; 16. ECT and neuromodulation therapies David
Christmas and Keith Matthews; Part III. Specific Therapeutic Areas: 17.
Drug treatment in childhood and adolescence David Coghill and Nicoletta
Adamo; 18. Drug treatment in later life Simon J. C. Davies; 19. Prescribing
in pregnancy and lactation Angelika Wieck and Ian Jones; 20. The clinical
management of acute disturbance including rapid tranquilisation Faisil
Sethi, Caroline Parker, Aileen O'Brien and Maxine X. Patel; 21.
Antipsychotics, weight gain and metabolic risk Stephen J. Cooper and Gavin
P. Reynolds; Index.